Peng R - Search Results

1

FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma.

Wang D, Han S, Peng R, Wang X, Yang XX, Yang RJ, Jiao CY, Ding D, Ji GW, Li XC. Wang D, et al. Among authors: peng r. Biochem Biophys Res Commun. 2015 Mar 6;458(2):313-20. doi: 10.1016/j.bbrc.2015.01.108. Epub 2015 Jan 31. Biochem Biophys Res Commun. 2015. PMID: 25646692

2

DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling.

Wang D, Han S, Peng R, Jiao C, Wang X, Han Z, Li X. Wang D, et al. Among authors: peng r. Int J Oncol. 2014 Dec;45(6):2596-604. doi: 10.3892/ijo.2014.2653. Epub 2014 Sep 16. Int J Oncol. 2014. PMID: 25230705

3

SOX5 promotes epithelial-mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma.

Wang D, Han S, Wang X, Peng R, Li X. Wang D, et al. Among authors: peng r. Med Oncol. 2015 Feb;32(2):461. doi: 10.1007/s12032-014-0461-2. Epub 2015 Jan 9. Med Oncol. 2015. PMID: 25572815

4

Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.

Wang D, Han S, Peng R, Jiao C, Wang X, Yang X, Yang R, Li X. Wang D, et al. Among authors: peng r. J Exp Clin Cancer Res. 2016 Feb 25;35:37. doi: 10.1186/s13046-016-0311-5. J Exp Clin Cancer Res. 2016. PMID: 26911146 Free PMC article.

5

Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.

Huang C, Tian Y, Peng R, Zhang C, Wang D, Han S, Jiao C, Wang X, Zhang H, Wang Y, Li X. Huang C, et al. Among authors: peng r. J Gastroenterol Hepatol. 2015 Feb;30(2):421-33. doi: 10.1111/jgh.12722. J Gastroenterol Hepatol. 2015. PMID: 25168293

6

Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.

Xiong X, Wu M, Zhang H, Li J, Lu B, Guo Y, Zhou T, Guo H, Peng R, Li X, Tian Q, Wang Y. Xiong X, et al. Among authors: peng r. Int J Oncol. 2015 Oct;47(4):1321-8. doi: 10.3892/ijo.2015.3103. Epub 2015 Jul 24. Int J Oncol. 2015. PMID: 26240015

7

PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.

Zhang L, You W, Zhang H, Peng R, Zhu Q, Yao A, Li X, Zhou Y, Wang X, Pu L, Wu J. Zhang L, et al. Among authors: peng r. J Gastroenterol Hepatol. 2015 May;30(5):821-9. doi: 10.1111/jgh.12889. J Gastroenterol Hepatol. 2015. PMID: 25641744

8

The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p.

Yang X, Cai JB, Peng R, Wei CY, Lu JC, Gao C, Shen ZZ, Zhang PF, Huang XY, Ke AW, Shi GM, Fan J. Yang X, et al. Among authors: peng r. J Cell Physiol. 2019 Jul;234(7):12051-12060. doi: 10.1002/jcp.27869. Epub 2018 Dec 10. J Cell Physiol. 2019. PMID: 30537113 Free PMC article.

9

Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.

Zhang PF, Wei CY, Huang XY, Peng R, Yang X, Lu JC, Zhang C, Gao C, Cai JB, Gao PT, Gao DM, Shi GM, Ke AW, Fan J. Zhang PF, et al. Among authors: peng r. Mol Cancer. 2019 Jun 1;18(1):105. doi: 10.1186/s12943-019-1031-1. Mol Cancer. 2019. PMID: 31153371 Free PMC article.

10

(-)-Curine induces cell cycle arrest and cell death in hepatocellular carcinoma cells in a p53-independent way.

Gong S, Xu D, Zou F, Peng R. Gong S, et al. Among authors: peng r. Biomed Pharmacother. 2017 May;89:894-901. doi: 10.1016/j.biopha.2017.01.148. Epub 2017 Mar 7. Biomed Pharmacother. 2017. PMID: 28292017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,007 results

Search Page

Filters